Eton Pharmaceuticals Inc. (ETON) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Eton Pharmaceuticals Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Eton Pharmaceuticals Inc. (ETON) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $1.5B. It trades at $51.80, up 1.25% today, at 114 times earnings. Its overall quality score is 71 out of 100, ranked against the whole US market. 3 analysts' average target of $71.33 implies +37.7% from today's price. Kronos AI's 30-day forecast is −0.2% (4 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $71.33 |
| Low – high | $68.00 – $76.00 |
| Analysts | 3 |
| Upside to average | +37.7% |
Kronos AI 30-day forecast
| Expected close | $51.04 (−0.2%) |
| Likely range | −8.5% … +8.8% |
| As of | 2026-10-27 |
Quality scores
| Profitability | 75 |
| Solvency | 53 |
| Growth | 85 |
| Overall | 71 |
| P/E | 114 |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Halal Health Care stocks · Zakat calculator · Purification calculator